Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 8 results for "fy03"

Hong Leong Research maintains Hold on Pos

KUALA LUMPUR: Hong Leong Research has maintained its Hold call on Pos Malaysia with a lower target price of RM4.60, saying that the national courier would be hit by higher cost structure. In a note on Friday, HLIB said Pos would be incurring steep ..., 1 week ago

4 images for fy03, 3 months ago
The Freepress Journal, 2 months ago, 3 months ago, 3 months ago

Solar Energy Market in India 2014 - 2022

The Solar Energy Market in India is expected to reach US$ 41.73 billion by 2022. FEATURED COMPANIES Central Electronics Ltd. Indosolar Ltd. Lumos Design Technology Ritika Systems Pvt. Ltd. Surana Ventures Ltd. Titan Energy Systems ...
 Research and Markets1 month ago Wind Energy Market in India 2014 - 2022  Research and Markets1 month ago

Bharat Book Bureau: Therapeutic Class Overview : Emergence of Biogenerics Era In Japan - It's Time to Welcome Antibody Biosimilars of Foreign Origins Soon

With three products and eight players already in market - Japan biosimilar market will enter new phase of biosimilars with first 'mab' approval expected in 2014. This approval (Remicade- FY03/13A sales 73.5, infiximab from Nippon Kayaku by YE 14) ...
 Pharmacy Choice1 month ago

Buy Power Grid; target of Rs 149: ICICIdirect`s research report on Power Grid Corporation of India Power Grid Corporation (PGCIL) is the only listed player in the regulated transmission business in India with 50% share in the segment. PGCIL's transmission infrastructure ...
 Moneycontrol.com1 month ago

M&A initiate coverage on KLK

PETALING JAYA: M&A Securities initiatiated its coverage on Kuala Lumpur Kepong Bhd with a 'hold' call and a target price of RM25.77 premised on strong management with good track record, land bank prime age profile, sizeable planted land bank and ...
 The Sun Daily1 month ago

Cadila Healthcare up 2% on USFDA nod for Kidney stones drug

Shares of Cadila Healthcare rallied as much as 2.4 percent intraday Thursday on getting final approval from USFDA for drug that is used in prevention of kidney stones. "Zydus Cadila has received the final approval from the United States Food and ...
 Moneycontrol.com1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less